Back to homepage

Tag "Covaxin"

Review process begins for WHO listing of Covaxin: Bharat Biotech

Review process begins for WHO listing of Covaxin: Bharat Biotech

🕔07:12, 13.Jul 2021

Hyderabad, July 13  Bharat Biotech on Monday said that it has submitted all documents to the World Health Organisation (WHO) for Emergency Use Listing (EUL) of its Covid-19 vaccine Covaxin and the review process has commenced. Bharat Biotech Chairman and

Read Full Article
CISF takes over security of Bharat Biotech

CISF takes over security of Bharat Biotech

🕔08:53, 15.Jun 2021

Hyderabad, June 15  The Central Industrial Security Force (CISF) on Monday took over the security of Bharat Biotech International Ltd’s facility here to protect it against any terror threat or sabotage that may lead to a biological disaster. The CISF

Read Full Article
Ocugen gets Covaxin commercialisation rights for Canada too

Ocugen gets Covaxin commercialisation rights for Canada too

🕔20:18, 3.Jun 2021

Hyderabad, June 3  Biopharmaceutical company Ocugen Inc will have exclusive co-development, manufacturing, and commercialisation rights to Bharat Biotech’s Covaxin in Canada, in addition to its existing US rights. Ocugen and Hyderabad-based Bharat Biotech on Thursday announced that they have entered

Read Full Article
Haffkine Biopharma to produce 22.8 cr doses of Covaxin per annum

Haffkine Biopharma to produce 22.8 cr doses of Covaxin per annum

🕔15:19, 2.Jun 2021

New Delhi, June 2  The Centre on Wednesday took steps to accelerate domestic vaccine production. Mumbai-based Haffkine Biopharma will produce 22.8 crore doses per annum of Covaxin under technology transfer arrangement with Bharat Biotech. With the aim of vaccinating the

Read Full Article
Covaxin production to reach 10 cr doses per month by Sep: Health Ministry

Covaxin production to reach 10 cr doses per month by Sep: Health Ministry

🕔08:42, 29.May 2021

New Delhi, May 29  Amid shortage of Covid vaccine jabs in the country, the Union Health and Family Welfare Ministry on Friday said that the production capacity will reach nearly 10 crore doses per month by September. “The current production

Read Full Article
Bharat Biotech expects WHO approval for Covaxin by July-Sep

Bharat Biotech expects WHO approval for Covaxin by July-Sep

🕔07:44, 26.May 2021

Hyderabad, May 26  Bharat Biotech has said on Tuesday that it is expecting regulatory approvals from the World Health Organisation (WHO) for its Covid-19 vaccine Covaxin by July-September 2021. The Hyderabad-based company stated that application for Emergency Use Listing (EUL)

Read Full Article
Bharat Biotech refuse more Covaxin to Delhi, Covishield stock to reach today

Bharat Biotech refuse more Covaxin to Delhi, Covishield stock to reach today

🕔14:56, 12.May 2021

New Delhi, May 12  There is no stock of — Covaxin for those between 18-45 of age and around 100 newly setup vaccination centers at government schools will administer Covishield only. The Kejriwal administration said, as of now, there is

Read Full Article
Bharat Biotech cuts price of Covaxin for states

Bharat Biotech cuts price of Covaxin for states

🕔07:23, 30.Apr 2021

Hyderabad, April 30  Bharat Biotech on Thursday announced that it is slashing the price of its Covid-19 vaccine Covaxin to Rs 400, from Rs 600 earlier, for state governments. The announcement came a day after the Serum Institute of India

Read Full Article
Bharat Biotech’s announcement to spark debate on Covid vax pricing

Bharat Biotech’s announcement to spark debate on Covid vax pricing

🕔18:03, 25.Apr 2021

Hyderabad, April 25  Bharat Biotech’s pricing announcement of its Covid-19 vaccine, Covaxin on Saturday is likely to further intensify the debate on pricing as the critics have slammed both the vaccine manufacturers for ‘profiteering’. However, Bharat Biotech, like Serum Institute

Read Full Article
‘Covaxin demonstrates overall interim clinical efficacy of 78%’

‘Covaxin demonstrates overall interim clinical efficacy of 78%’

🕔19:47, 21.Apr 2021

Hyderabad, April 21  Leading vaccine maker Bharat Biotech and the Indian Council of Medical Research (ICMR) on Wednesday announced interim results from phase 3 clinical trials of Covaxin, which show 78 per cent overall clinical efficacy and 100 per cent

Read Full Article
Delhi govt diverts Covaxin to 6 Centre-run hospitals

Delhi govt diverts Covaxin to 6 Centre-run hospitals

🕔13:04, 15.Jan 2021

New Delhi, Jan 15  The Delhi government has rationed the tranche of two Covid-19 vaccines it has stocked in 81 hospitals finalised for the launch of a massive immunization drive against the novel coronavirus in the national capital. However, the

Read Full Article
Covaxin works against UK strain, will release study by Jan 10: Bharat Biotech CMD

Covaxin works against UK strain, will release study by Jan 10: Bharat Biotech CMD

🕔20:11, 4.Jan 2021

New Delhi, Jan 4  Hyderabad-based Bharat Biotech said on Monday that its vaccine is efficient against the mutant strain of novel coronavirus found in the UK while announcing that its data would be made public within a week. CMD Dr

Read Full Article
Bharat Biotech dispatches 1st batch of Covaxin for immunisation drive

Bharat Biotech dispatches 1st batch of Covaxin for immunisation drive

🕔19:00, 4.Jan 2021

New Delhi, Jan 4  Hyderabad-based Bharat Biotech has sent the first batch of its Covid vaccine, Covaxin, to the government for further distribution in the immunisation drive the country is set to start in coming days, its CMD Dr Krishna

Read Full Article
Vaccine: DCGI panel to meet Bharat Biotech officials shortly

Vaccine: DCGI panel to meet Bharat Biotech officials shortly

🕔13:09, 2.Jan 2021

New Delhi, Jan 2  A committee of experts assessing the coronavirus vaccines has called Hyderabad-based Bharat Biotech for a meeting at 1.30 pm on Saturday, a day after the firm was asked to present more data on its ‘Covaxin’ to

Read Full Article
Covaxin can deal with new Covid strains too: Bharat Biotech

Covaxin can deal with new Covid strains too: Bharat Biotech

🕔07:21, 30.Dec 2020

Hyderabad, Dec 30  Bharat Biotech said on Tuesday that its vaccine candidate, Covaxin, will be effective in dealing with new strains of coronavirus. Bharat Biotech Chairman and Managing Director Krishna Ella said the protein components of inactive Covaxin will take

Read Full Article
‘Covaxin likely to be available for public use by Feb in India’

‘Covaxin likely to be available for public use by Feb in India’

🕔13:27, 9.Dec 2020

New Delhi, Dec 8 (IANS) Covaxin, the COVID vaccine candidate by Hyderabad-based vaccine manufacturer Bharat Biotech Limited, being developed in collaboration with the Indian Council of Medical Research (ICMR), is likely to be available for use of the general public by

Read Full Article
‘Covaxin likely to be available for public use by Feb’

‘Covaxin likely to be available for public use by Feb’

🕔05:49, 9.Dec 2020

New Delhi, Dec 9  Covaxin, the COVID vaccine candidate by Hyderabad-based vaccine manufacturer Bharat Biotech Limited, being developed in collaboration with the Indian Council of Medical Research (ICMR), is likely to be available for use of the general public by

Read Full Article
Covaxin trial to begin in Bengaluru hospital on Wed

Covaxin trial to begin in Bengaluru hospital on Wed

🕔07:03, 2.Dec 2020

Bengaluru, Dec 2  The Phase-III clinical trial of Covid-19 vaccine (Covaxin) being developed by Bharat Biotech would begin at the privately-run Vydehi multi-specialty hospital here from Wednesday, an official said on Tuesday. “The ICMR (Indian Council of Medical Research) has

Read Full Article
Covaxin may be launched in early 2021, says AIIMS doctor

Covaxin may be launched in early 2021, says AIIMS doctor

🕔07:41, 9.Sep 2020

New Delhi, Sep 9  Covid-19 is raging like a wild fire across the country, making India the second worst hit country after the US. But there is a bright spot amid this mayhem — India’s first indigenous Covid-19 vaccine, Covaxin

Read Full Article
COVAXIN 2nd phase clinical testing in Gauhati Medical College

COVAXIN 2nd phase clinical testing in Gauhati Medical College

🕔08:29, 19.Aug 2020

Guwahati, Aug 19  The Gauhati Medical College and Hospital (GMCH) has been selected for the second phase clinical testing of India’s indigenously developed coronavirus vaccine, COVAXIN, Assam Health Minister Himanta Biswa Sarma said on Tuesday. He said the GMCH would

Read Full Article

Search the Website

Advertiser’s Logos

Water Conservation

पानी की बर्बादी वाहनों को धोने में सबसे ज्यादा होती है, इससे बचने के लिए आपको हर दिन अपने वाहनों को कपड़े से साफ करते रहना चाहिए। जिससे वाहनों को धोने की जरूरत कम पड़ेगी।

Sarkaritel.com Interview with U P Singh (IAS), Secretary, Ministry of Jal Shakti & Drinking Water & Sanitation by Ameya Sathaye, Publisher & Editor-in-Chief, Sarkaritel.com

HEALTH PARTNER